BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34375682)

  • 1. Microneedle-Mediated Vaccination: Innovation and Translation.
    Sheng T; Luo B; Zhang W; Ge X; Yu J; Zhang Y; Gu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():113919. PubMed ID: 34375682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
    Chen MC; Huang SF; Lai KY; Ling MH
    Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedles: A New Generation Vaccine Delivery System.
    Menon I; Bagwe P; Gomes KB; Bajaj L; Gala R; Uddin MN; D'Souza MJ; Zughaier SM
    Micromachines (Basel); 2021 Apr; 12(4):. PubMed ID: 33919925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
    Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
    Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
    Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
    Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural design strategies of microneedle-based vaccines for transdermal immunity augmentation.
    Xu G; Mao Y; Jiang T; Gao B; He B
    J Control Release; 2022 Nov; 351():907-922. PubMed ID: 36216175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedles for drug and vaccine delivery.
    Kim YC; Park JH; Prausnitz MR
    Adv Drug Deliv Rev; 2012 Nov; 64(14):1547-68. PubMed ID: 22575858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery systems for intradermal vaccination.
    Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
    Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances of microneedles in hormone delivery.
    Nguyen TT; Nguyen TTD; Tran NM; Vo GV
    Biomed Pharmacother; 2022 Jan; 145():112393. PubMed ID: 34773762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of vaccine formulations: past, present, and future.
    D'Amico C; Fontana F; Cheng R; Santos HA
    Drug Deliv Transl Res; 2021 Apr; 11(2):353-372. PubMed ID: 33598818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.